In HCC, ILF2 overexpression promotes cell proliferation by stabilizing cAMP-response element-binding proteins (CREB) and activating the epidermal growth factor receptor (EGFR)/protein kinase B (AKT) signaling pathway (32). Here, AKT1 is linked to hepatocellular carcinoma.